Generic drug
Clobazam price, strengths & recalls
Pharmacies pay $21.87 for 120 mL of Clobazam 2.5 mg/mL oral suspension this week, and from $7.31 to $21.87 across its 3 priced strengths and forms. 15 manufacturers make it. 3 recalls are ongoing. Its official label last changed on July 1, 2026.
3 open recallsGeneric- Fair cash price
- $35.65
- Strengths
- 3
- Makers
- 15
- Updated
- Nov 11
Clobazam price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 2.5 mg/mL oral suspension | $0.1822 | $21.87 / 120 mL |
| 10 mg tablet | $0.2438 | $7.31 / 30 tablets |
| 20 mg tablet | $0.3762 | $11.29 / 30 tablets |
The lowest cost per tablet is 10 mg tablet at $0.2438. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Brand names of clobazam
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Supply status: shortages & recalls
Recalls
Showing the 6 most relevant of 7 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Clobazam
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use CLOBAZAM TABLETS safely and effectively. See full prescribing information for CLOBAZAM TABLETS. CLOBAZAM tablets, for oral use, CIVInitial U.S. Approval: 2011
WARNING: RISKS FROM
CONCOMITANT USE WITH OPIOIDS;
ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS
Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation [see Warnings and Precautions (5.1), Drug Interactions (7.1)].
The use of benzodiazepines, including clobazam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Abuse and misuse of benzodiazepines commonly involve concomitant use of other medications, alcohol, and/or illicit substances, which is associated with an increased frequency of serious adverse outcomes. Before prescribing clobazam and throughout treatment, assess each patient's risk for abuse, misuse, and addiction [see Warnings and Precautions (5.2)].
The continued use of benzodiazepines, including clobazam, may lead to clinically significant physical dependence. The risks of dependence and withdrawal increase with longer treatment duration and higher daily dose. Abrupt discontinuation or rapid dosage reduction of clobazam after continued use may precipitate acute withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue clobazam or reduce the dosage [see Dosage and Administration (2.2) and Warnings and Precautions (5.3)].
WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS
See full prescribing information for complete boxed warning.
Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation. (5.1, 7.1)
The use of benzodiazepines, including clobazam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Before prescribing clobazam and throughout treatment, assess each patient's risk for abuse, misuse, and addiction. (5.2)
Abrupt discontinuation or rapid dosage reduction of clobazam after continued use may precipitate acute withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue clobazam or reduce the dosage. (2.2, 5.3)
Recent major changes (as listed on the label)
Warnings and Precautions (5.7) 3/2024
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA210833 · Cosette
- First approved
- November 1, 2018 (8 years ago)
- Latest approved change
- March 12, 2024
- Approved label
- PDF, Mar 13, 2024
- Generic makers
- 14 approved generic applications on the market
- Last patent listed
- January 31, 2040
Clobazam questions
How much does clobazam cost without insurance?
Pharmacies pay about $21.87 for 120 mL of clobazam 2.5 mg/mL oral suspension ($0.1822 per mL). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $35.65. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of clobazam?
Is clobazam in shortage?
No shortage is reported for clobazam right now. We check the national shortage list every day.
Has clobazam been recalled?
7 recalls on record, 3 ongoing. Recalls name specific lots - check yours.
When did the clobazam label last change?
The official label was last updated on July 1, 2026 (version 10). See what changed.
Talk about clobazam
No comments yet. Questions, tips, what worked for you - start the conversation.